🔎 Trials Near Me

Pradžia › Alergija › Kalifornija

Alergija klinikiniai tyrimai Kalifornija

7 tyrimai dėl Alergija ieško dalyvių vietose Kalifornija.

Miestai Kalifornija

Oficialus tyrimo tekstas (anglų kalba)

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCLA Medical Center, Los Angeles
  • Stanford Cancer Institute, Stanford
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT04996875

Study of Oral Food Challenge Biomarkers (SAFER)

  • Stanford School of Medicine: Sean N. Parker Center for Allergy & Asthma Research, Palo Alto
Renkami dalyviaiStebimasis tyrimas
12 Months – 17 Years · Visoms lytims · Atnaujinta 2026-09-09 · NCT07279467

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • University of San Francisco, San Francisco
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT07059091

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

  • University of California, San Francisco, San Francisco
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-04 · NCT06406114

Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

  • Orso Health, Inc., La Jolla
Renkami dalyviai4 fazė
Amžius 4 ir vyresni · Visoms lytims · Atnaujinta 2026-04-21 · NCT06834165

Understanding Allergies and Sensitizations in Healthy and Allergic Individuals

  • Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
1 Week – 90 Years · Visoms lytims · Atnaujinta 2026-03-17 · NCT04828603

Food Allergy Registry at a Single Site

  • Stanford University, Palo Alto
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 0 iki 100 · Visoms lytims · Atnaujinta 2025-11-14 · NCT03539705

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.